Capital Asset Advisory Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,087
| Closed | -$226K | – | 318 |
|
|
2023
Q2 | $226K | Sell |
1,087
-200
| -16% | -$41.5K | 0.02% | 301 |
|
|
2023
Q1 | $260K | Sell |
1,287
-63
| -5% | -$12.7K | 0.02% | 287 |
|
|
2022
Q4 | $321K | Sell |
1,350
-1,709
| -56% | -$406K | 0.03% | 258 |
|
|
2022
Q3 | $602K | Sell |
3,059
-1,322
| -30% | -$260K | 0.08% | 146 |
|
|
2022
Q2 | $937K | Buy |
4,381
+82
| +2% | +$17.5K | 0.1% | 137 |
|
|
2022
Q1 | $1.22M | Buy |
4,299
+663
| +18% | +$188K | 0.13% | 105 |
|
|
2021
Q4 | $1.37M | Buy |
3,636
+203
| +6% | +$76.5K | 0.15% | 96 |
|
|
2021
Q3 | $1.42M | Buy |
3,433
+32
| +0.9% | +$13.2K | 0.16% | 87 |
|
|
2021
Q2 | $1.26M | Buy |
3,401
+355
| +12% | +$131K | 0.14% | 100 |
|
|
2021
Q1 | $883K | Buy |
3,046
+390
| +15% | +$113K | 0.13% | 144 |
|
|
2020
Q4 | $664K | Buy |
2,656
+268
| +11% | +$67K | 0.12% | 150 |
|
|
2020
Q3 | $541K | Sell |
2,388
-187
| -7% | -$42.4K | 0.11% | 147 |
|
|
2020
Q2 | $541K | Buy |
2,575
+42
| +2% | +$8.82K | 0.12% | 157 |
|
|
2020
Q1 | $408K | Buy |
2,533
+364
| +17% | +$58.6K | 0.11% | 157 |
|
|
2019
Q4 | $376K | Buy |
+2,169
| New | +$376K | 0.09% | 221 |
|